2Kass JS,Shandera WX.Nervous system effects of antitubercu-losis therapy[J].CNS Drugs,2010,24(8):655-667.
3Menon V,Jain D,Saxena R,et al.Prospective evaluation of vi-sual function for early detection of ethambutol toxicity[J].BrJ Ophthalmol,2009,93(9):1251-1254.
4Talbert KA,Sadun AA.Risk factors for ethambutol optic toxic-ity[J].Int Ophthalmol,2010,30(1):63-72.
5Chung H,Yoon YH,Hwang JJ,et al.Ethambutol-induced toxi-city is mediated by zinc and lysosomal membrane perme-abilization in cultured retinal cells[J].Toxicol Appl Pharma-col,2009,235(2):163-170.
3CARR RE, HENKIND P. Ocular manifestations of ethambutol, Toxic amblyopia after administration of an experimental antituber- culous drug [ J ]. Arch Ophthalmol, 1962,67:566-571.
4Chen HY, Lai SW, Muo CH, et al. Ethambutol-induced optic neuropathy : a nationwide population-based study from Taiwan[ J]. Br J Ophthalmol, 2012,96 ( 11 ) : 1368-1371.
5Kass JS, Shandera WX. Nervous system effects of antituberculosis therapy[ J]. CNS Drugs, 2010,24 (8) ;655-667.
6Kandel H, Adhikari P, Shrestha GS, et al. Visual function in pa- tients on ethambutol therapy for tuberculosis [ J ]. J Ocul Pharma- col Ther, 2012,28(2) :174-178.
